Expertise in
4
conditions

Alain Hendlisz

Brussels, BRU, BE 
Expertise in
4
conditions
Brussels, BRU, BE 

Overview

Alain Hendlisz practices practicing medicine in Brussels, Belgium.

Mr. Hendlisz is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Liver Cancer, Febrile Neutropenia, Hepato-Pancreato-Biliary Surgery, and Liver Embolization.

He is actively involved in clinical research, co-authoring 139 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Brussels, BRU, Belgium
Other Locations
Namur, WAL, Belgium
Schaerbeek, BRU, Belgium
Rue Meylemeersch 90, Anderlecht, BRU 1070, Belgium
Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
Enrollment Status: Terminated
Publish Date: October 21, 2025
Intervention Type: Drug
Study Phase: Phase 1
INtegratioN of Trastuzumab, With or Without Pertuzumab, Into periOperatiVe chemotherApy of HER-2 posiTIve stOmach caNcer: the INNOVATION-TRIAL
INtegratioN of Trastuzumab, With or Without Pertuzumab, Into periOperatiVe chemotherApy of HER-2 posiTIve stOmach caNcer: the INNOVATION-TRIAL
Enrollment Status: Completed
Publish Date: July 31, 2025
Intervention Type: Drug, Procedure
Study Drugs: Cisplatin, 5-fluorouracil or Capecitabine, Trastuzumab, Pertuzumab
Study Phase: Phase 2
An Open-label Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer
An Open-label Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer
Enrollment Status: Terminated
Publish Date: February 28, 2024
Intervention Type: Biological
Study Drug: NKR-2 Cells
Study Phase: Phase 1
Preoperative Chemosensitivity Testing as Predictor of Treatment Benefit in Adjuvant Stage III Colon Cancer: PePiTA Trial
Preoperative Chemosensitivity Testing as Predictor of Treatment Benefit in Adjuvant Stage III Colon Cancer: PePiTA Trial
Enrollment Status: Completed
Publish Date: August 07, 2023
Intervention Type: Drug
Study Drug: FOLFOX
Study Phase: Not Applicable
Correlating the Tumoral Metabolic Progression Index Measured by Serial FDG PET-CT and Apparent Diffusion Coefficient Measured by MRI to Patient's Outcome in Advanced Colorectal Cancer
Correlating the Tumoral Metabolic Progression Index Measured by Serial FDG PET-CT and Apparent Diffusion Coefficient Measured by MRI to Patient's Outcome in Advanced Colorectal Cancer
Enrollment Status: Completed
Publish Date: October 26, 2021
Intervention Type: Other
Study Phase: Not Applicable
An Open Label, Single Arm Pilot Study of OncoSil™, Administered to Study Participants With Unresectable Locally Advanced Pancreatic Adenocarcinoma, Given in Combination With FOLFIRINOX or Gemcitabine+Nab-paclitaxel Chemotherapies
An Open Label, Single Arm Pilot Study of OncoSil™, Administered to Study Participants With Unresectable Locally Advanced Pancreatic Adenocarcinoma, Given in Combination With FOLFIRINOX or Gemcitabine+Nab-paclitaxel Chemotherapies
Enrollment Status: Completed
Publish Date: July 13, 2021
Intervention Type: Device
Study Phase: Not Applicable
An Open-label, Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2, Administered Concurrently With the Neoadjuvant FOLFOX Treatment in Patients With Potentially Resectable Liver Metastases From Colorectal Cancer
An Open-label, Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2, Administered Concurrently With the Neoadjuvant FOLFOX Treatment in Patients With Potentially Resectable Liver Metastases From Colorectal Cancer
Enrollment Status: Unknown
Publish Date: June 16, 2020
Intervention Type: Biological
Study Drug: NKR-2 Cells
Study Phase: Phase 1
View 6 Less Clinical Trials

139 Total Publications

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.
5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.
Journal: Current opinion in oncology
Published: June 04, 2026

Frequently Asked Questions about Alain Hendlisz

Is Alain Hendlisz a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Alain Hendlisz is classified as an Elite expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alain Hendlisz participate in research or clinical trials?

Yes. Alain Hendlisz has published 139 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Alain Hendlisz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hendlisz's expertise for a condition
ConditionClose
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile